01-11-2000 | ORIGINAL ARTICLE
N-Methyl-1-deoxynojirimycin (MOR-14), an α-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction
Published in: Heart and Vessels | Issue 6/2000
Login to get access01-11-2000 | ORIGINAL ARTICLE
Published in: Heart and Vessels | Issue 6/2000
Login to get access